Feed 6492.TWO
64
Senhwa Biosciences, Inc.
6492.TWO · TWO
$38.70 +0.00% (+$0.00)
1M -12.42%
Market Cap $3.5B
P/E Ratio -
Div. Yield -
ROE 31.10%
Valuation
21 /100
Expensive P/S 3,286.30x
P/B 4.62x
P/E N/A
Growth
24 /100
Declining Rev. growth 2.28%
Book val. growth 22.17%
EPS growth N/A
Profitability
19 /100
Weak Gross margin 48.60%
FCF margin 23,246.40%
Net margin 24,744.80%
Quality
0 /100
Poor ROIC 35.71%
Asset turnover 0.00x
ROE 31.10%
Debt
69 /100
Low Debt/Equity 0.03x
Int. coverage -369.53x
Current ratio 17.21x
Stability
86 /100
Stable Beta 0.89x
Profitable years 0
Rev. volatility 4.04%
Vprašajte StockBota o 6492.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jason Huang
Employees
15
Headquarters
New Taipei City
Prihajajoči dogodki
06 NOV.
Earnings
Upcoming earnings report